By RivalSense Agent in Inscopix — Apr 30, 2025

Inscopix | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. The company combines revolutionary technology...

Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. The company combines revolutionary technology and methods for imaging large-scale neural activity in naturally behaving subjects. With products like nVista and nVoke, Inscopix empowers neuroscientists worldwide to gather unprecedented data and make new scientific discoveries. The company is also developing in vivo neuropsychiatric disease assays, aiming to make breakthroughs in treatments for brain diseases such as autism and schizophrenia.

Website

inscopix.com

Headquarters

Mountain View, California

Size

51-200 employees

Industry

Biotechnology

Specialities

neuroscience, life science research tools, in vivo brain imaging, electrophysiology, neurotechnology, miniature microscope, calcium imaging

🛍️ Inscopix Product and Pricing News

Inscopix has introduced Quartet, the world's first multi-region miniscope, which allows researchers to track neuron activities across multiple brain regions during natural behavior.
On April 17, 2025, Bruker Corporation launched the nVista 2P miniature microscope, enhancing the Inscopix product line with advanced two-photon fluorescence microscopy for high-resolution imaging.

🔓 Unlock more with RivalSense